T-686, a novel inhibitor of plasminogen activator inhibitor-1, inhibits thrombosis without impairment of hemostasis in rats - II. Effects on hemostasis, thrombosis and thrombolysis

By Ohtani A.   Murakami J.   Hirano-Wakimoto A.  

European Journal of Pharmacology, Vol. 330, Iss. 2, 1997-07 ,pp. : 151-156

Elsevier

Access to resources Recommend Favorite

Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis

By Heran C.   Morgan S.   Kasiewski C.   Bostwick J.   Bentley R.   Klein S.   Chu V.   Brown K.   Colussi D.   Czekaj M.   Perrone M.   Leadley R.  

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 201-207

Elsevier

Access to resources Recommend Favorite

Influence of food on the pharmacokinetics of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor

By Holdich Tom   Sawyer James  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2021-2025

Informa Healthcare

Access to resources Recommend Favorite

Novel approaches to the treatment of thrombosis

By Gresele P.   Agnelli G.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 1, 2002-01 ,pp. : 25-32

Elsevier

Access to resources Recommend Favorite

Anti-platelet and anti-thrombosis characteristics of Z4A5, a novel selective platelet glycoprotein IIb/IIIa inhibitor, compared with eptifibatide under long-term infusion

By Shi X.L.   Shen S.   Guo M.M.   Zhang G.J.   Che J.   Wang B.   Zhou J.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 12, 2015-12 ,pp. : 810-814

Govi-Verlag

Access to resources Recommend Favorite